BESREMI vs JAKAFI XR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BESREMI and JAKAFI XR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BESREMI	JAKAFI XR
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ROPEGINTERFERON ALFA-2B-NJFT	RUXOLITINIB PHOSPHATE
Manufacturer	Pharmaessentia Corp	Incyte Corp
Dosage forms	Injectable	Tablet, extended release
Drug class	—	Janus Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Polycythemia Vera	Polycythemia Vera, Primary Myelofibrosis

besremi jakafi xr

Rating

New

Pharmacy pays

—

Type

Active ingredient

ROPEGINTERFERON ALFA-2B-NJFT

RUXOLITINIB PHOSPHATE

Manufacturer

Pharmaessentia Corp

Incyte Corp

Dosage forms

Injectable

Tablet, extended release

Drug class

—

Janus Kinase Inhibitor

Boxed warning

None

Treats

Polycythemia Vera

Polycythemia Vera, Primary Myelofibrosis

Frequently asked questions

What is the difference between Besremi and Jakafi XR?

Besremi contains Ropeginterferon Alfa-2b-Njft, while Jakafi XR contains Ruxolitinib Phosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.